AFMD — Affimed NV Income Statement
0.000.00%
Last trade - 00:00- $82.99m
- $48.24m
- €8.28m
Annual income statement for Affimed NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 21.4 | 28.4 | 40.4 | 41.4 | 8.28 |
| Cost of Revenue | |||||
| Gross Profit | 19.8 | 26.6 | 38.2 | 39.2 | 6.93 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 53.8 | 63.1 | 104 | 129 | 115 |
| Operating Profit | -32.4 | -34.7 | -64 | -88.1 | -107 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -32.4 | -41.4 | -57.5 | -86 | -106 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -32.4 | -41.4 | -57.5 | -86 | -106 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -32.4 | -41.4 | -57.5 | -86 | -106 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -32.4 | -41.4 | -57.5 | -86 | -106 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -5.04 | -4.96 | -4.81 | -6.04 | -7.09 |